Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Osnat Jarchowsky Dolberg

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Autoimmunity Reviews|January 16, 2014
Idiopathic aplastic anemia: diagnosis and classificationOsnat Jarchowsky Dolberg, Yair Levy
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 24, 2012
Advanced (>second) line chemotherapy in the treatment of patients with recurrent epithelial ovarian cancerIlan Bruchim, Osnat Jarchowsky-Dolberg, Ami Fishman
Blood Cancer Journal|January 14, 2025
Fedratinib for the treatment of myelofibrosis: a critical appraisal of clinical trial and "real-world" dataAdrian Duek, Ilona Leviatan, Osnat Jarchowsky Dolberg, et al.
Carcinogenesis|October 6, 2019
Multiple myeloma BM-MSCs increase the tumorigenicity of MM cells via transfer of VLA4-enriched microvesiclesMahmoud Dabbah, Osnat Jarchowsky-Dolberg, Oshrat Attar-Schneider, et al.
Transfusion|April 3, 2026
Prothrombin complex concentrate for oral factor Xa inhibitor reversal prior to urgent invasive proceduresMohammad Shamiea, Alex Osnis, Awan Kashoua, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|April 22, 2021
Ribosomal proteins as distinct "passengers" of microvesicles: new semantics in myeloma and mesenchymal stem cells' communicationMahmoud Dabbah, Michael Lishner, Osnat Jarchowsky-Dolberg, et al.
Oncogenesis|April 11, 2025
Myeloma mesenchymal stem cells' bioenergetics afford a novel selective therapeutic targetOded Komemi, Elina Orbuch, Osnat Jarchowsky-Dolberg, et al.
British Journal of Haematology|June 17, 2025
Can we identify individuals at risk to develop multiple myeloma? A machine learning-based predictive modelMoshe Mittelman, Ariel Israel, Howard S Oster, et al.
Experimental Cell Research|December 26, 2024
Reduced elastin in multiple myeloma niche promotes cell proliferationMozayan Zoabi, Elina Orbuch, Oded Komemi, et al.
Journal of Clinical Medicine|March 28, 2026
Beyond Malignancy: Clinical Insights from Three Cases of Severe HypercalcemiaShani Ben Dori, Noor Kabaha, Amer Abu Husseine, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Autoimmunity Reviews|January 16, 2014
Idiopathic aplastic anemia: diagnosis and classificationOsnat Jarchowsky Dolberg, Yair Levy
European Journal of Obstetrics, Gynecology, and Reproductive Biology|October 24, 2012
Advanced (>second) line chemotherapy in the treatment of patients with recurrent epithelial ovarian cancerIlan Bruchim, Osnat Jarchowsky-Dolberg, Ami Fishman
Blood Cancer Journal|January 14, 2025
Fedratinib for the treatment of myelofibrosis: a critical appraisal of clinical trial and "real-world" dataAdrian Duek, Ilona Leviatan, Osnat Jarchowsky Dolberg, et al.
Carcinogenesis|October 6, 2019
Multiple myeloma BM-MSCs increase the tumorigenicity of MM cells via transfer of VLA4-enriched microvesiclesMahmoud Dabbah, Osnat Jarchowsky-Dolberg, Oshrat Attar-Schneider, et al.
Transfusion|April 3, 2026
Prothrombin complex concentrate for oral factor Xa inhibitor reversal prior to urgent invasive proceduresMohammad Shamiea, Alex Osnis, Awan Kashoua, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|April 22, 2021
Ribosomal proteins as distinct "passengers" of microvesicles: new semantics in myeloma and mesenchymal stem cells' communicationMahmoud Dabbah, Michael Lishner, Osnat Jarchowsky-Dolberg, et al.
Oncogenesis|April 11, 2025
Myeloma mesenchymal stem cells' bioenergetics afford a novel selective therapeutic targetOded Komemi, Elina Orbuch, Osnat Jarchowsky-Dolberg, et al.
British Journal of Haematology|June 17, 2025
Can we identify individuals at risk to develop multiple myeloma? A machine learning-based predictive modelMoshe Mittelman, Ariel Israel, Howard S Oster, et al.
Experimental Cell Research|December 26, 2024
Reduced elastin in multiple myeloma niche promotes cell proliferationMozayan Zoabi, Elina Orbuch, Oded Komemi, et al.
Journal of Clinical Medicine|March 28, 2026
Beyond Malignancy: Clinical Insights from Three Cases of Severe HypercalcemiaShani Ben Dori, Noor Kabaha, Amer Abu Husseine, et al.
Pageof 2